Exercise Enhances Body Composition, Nutritional Status in Dialysis Patients Younger patients are less likely to respond to treatment with sucroferric oxyhydroxide or sevelamer.

ISTANBUL, Turkey — The investigational drug PA21 controls hyperphosphatemia over the long term and has a lower pill burden than sevelamer carbonate, according to a phase 3 study. The cardiovascular ...

Sevelamer carbonate 800 mg; tabs. Patients with CKD can develop hyperphosphatemia as a result of retained phosphorus, which may lead to ectopic calcification. Hyperphosphatemia plays a role in the ...

Chronic Kidney Disease (CKD) is usually described in terms of numbers: Decreasing filtration rates, increasing creatinine, and changing electrolyte levels. But behind the laboratory values lies an ...

Tenapanor, a novel agent that has been submitted to the US Food and Drug Administration (FDA) for approval for the treatment of hyperphosphatemia in patients undergoing dialysis, moved a step closer ...

Please provide your email address to receive an email when new articles are posted on . In April, CMS issued guidance for the inclusion of oral-only drugs in the end-stage renal disease bundled ...

As a physician and researcher caring for people with chronic kidney disease, I see firsthand the challenges that patients undergoing dialysis face. Dialysis is life-sustaining, but it also brings ...